Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).
Clinical trial NCT03573401 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03573401
- Sponsor
- Biofrontera Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-25
- Primary completion
- 2024-03-19
- Enrollment
- 187
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.